Skip to content
MarketScale
‹ Back to IndustriesHealthcare

The Airborne Heroes behind Organ Transplant Procurement

The challenges healthcare executives and administrators face are constantly changing. Host Kevin Stevenson talks with the heroes behind the heroes that are enabling hospitals, urgent care centers and telemedicine operators to spend their time tending to patients, while they handle the logistics.   I Don’t Care seeks to bring conversations to the world that touch on many…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from I Don't Care on MarketScale.

Share

The challenges healthcare executives and administrators face are constantly changing. Host Kevin Stevenson talks with the heroes behind the heroes that are enabling hospitals, urgent care centers and telemedicine operators to spend their time tending to patients, while they handle the logistics.

I Don’t Care seeks to bring conversations to the world that touch on many healthcare topics. For a completely unique take, host Kevin Stevenson welcomed Jessie Naor, COO of GrandView Aviation. GrandView Aviation is a Part 135 certified aircraft operator. They transport organs for transplant and offer private charters.

Naor described the company’s origins. “We’ve been in the organ transplant transportation business for 12 years, starting with one helicopter. We now have 10 airplanes and serve multiple locations across the U.S.”

Hospitals mostly use the flights for organs with the shortest cold-time, including hearts, livers, and lungs. A typical procurement involves two pilots and two healthcare workers. They start at the home hospital, fly to the donor, retrieve the organ post-surgery, and return to their base.

Naor then discussed the importance of the FAA (Federal Aviation Administration) Part 135. Part 135 is different from Part 125, used by commercial airlines. It corresponds with private commercial, non-scheduled aircraft operations, requiring specific safety and operational protocols. Until the last few years, many organ transplant operations didn’t fly under Part 135.

“They were just flying private with few regulations. Now, it’s changed because of medivac accidents. There’s always risk, and you can never mitigate it 100 percent, but you should always ask operators how they’re doing it,” Naor shared.

Naor and GrandView have a mission to educate the healthcare industry and beyond about best practices and safety. Naor is currently on an FAA committee making suggestions to handle crew safety and organ transplant.

When asked what’s next for organ transplant, Naor said, “We don’t yet have drones, but people in the industry are trying to figure it out. I could see as being helpful within large cities.”

Listen to Previous Episodes of MarketScale’s I Don’t Care Right Here!

I Don't Care

Part of this channel

I Don't Care

Candid healthcare leadership conversations with Kevin Stevenson

Visit the channel

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's Healthcare expertise into the articles, video, and social content B2B marketing buyers in your industry are searching for. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Rebuilding Medicine Around Presence: The Future of Physician House Calls with Dr. Yevhen Pavelko, Founder of Inviah Health

Dr. Yevhen Pavelko, founder of Inviah Health, is advocating for the resurgence of physician house calls. He believes that personal interaction can significantly improve patient care and satisfaction. Inviah Health aims to modernize this traditional approach by integrating advanced medical technology.

  • 01Dr. Yevhen Pavelko supports the revival of physician house calls to improve patient care.
  • 02Inviah Health focuses on integrating advanced technology with traditional house call practices.
  • 03Personal interaction between doctors and patients can enhance care and satisfaction.

Jul 31, 2026

Tempus AI's $1.7B Personalis deal leads a surge in health-tech M&A that is already reshaping vendor choices for health system operators

Tempus AI's $1.7B Personalis deal leads a surge in health-tech M&A that is already reshaping vendor choices for health system operators

Digital health mergers and acquisitions (M&A) along with venture capital (VC) activities are rapidly increasing. Tempus AI's $1.7 billion acquisition of Personalis is part of a larger trend that is influencing health system operators’ selection of vendors. With $7.4 billion in funding during the first half of 2026, the health-tech industry is undergoing significant transformation.

  • 01Tempus AI acquired Personalis for $1.7 billion.
  • 02Health-tech received $7.4 billion in funding in the first half of 2026.
  • 03M&A activities are influencing vendor choices for health system operators.

Jul 30, 2026

Digital health AI investment hits $7.4B in H1 2026 as CMS, hospitals, and startups all accelerate adoption

Digital health AI investment hits $7.4B in H1 2026 as CMS, hospitals, and startups all accelerate adoption

In the first half of 2026, digital health AI investments reached $7.4 billion as organizations like CMS, hospitals, and startups increased their adoption of AI. Significant moves include the establishment of a new CMS technology office and a $1.7 billion acquisition in cancer technology. These developments mark an enterprise-level commitment to advancing AI in healthcare.

  • 01Digital health AI investments reached $7.4 billion in H1 2026.
  • 02The CMS established a new technology office to advance healthcare AI.
  • 03A major acquisition in cancer technology totaled $1.7 billion.

Jul 30, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512